12/01/2009 Piper Jaffray 21st Annual Health Care Conference Webcast
11/05/2009 Q3 2009 BioSpecifics Technologies Corp. Earnings Conference Call
09/16/2009 BioCentury “NewsMakers in the Biotech Industry” Conference Webcast
09/10/2009 Rodman & Renshaw 11th Annual Healthcare Conference Webcast
08/12/2009 Q2 2009 BioSpecifics Technologies Corp. Earnings Conference Call
07/29/2009 CapStone Investments’ Third Annual Small-Cap Investor Conference Webcast
03/16/2009 Cowen & Co. 29th Annual Health Care Conference Webcast
12/17/2008 Piper Jaffray 20th Annual Health Care Conference Webcast
12/01/2009 BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
02/02/2010 BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX™ for Treatment of Dupuytren’s Contracture
01/21/2010 BioSpecifics Technologies Corp. Announces Commencement of European Regulatory Review of XIAFLEX™ for the Treatment of Dupuytren’s Disease
12/16/2009 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX™ for Treatment of Peyronie’s Disease
11/24/2009 BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
11/06/2009 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
10/30/2009 BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009
09/16/2009 FDA Advisory Committee Unanimously Recommends Approval of XIAFLEX™ for Treatment of Dupuytren’s Disease
09/16/2009 BioSpecifics Technologies Corp. Stock Trading Halted Today
09/11/2009 BioSpecifics Technologies Corp. to Present at BioCentury “NewsMakers in the Biotech Industry” Conference
09/03/2009 BioSpecifics Technologies Corp. Announces XIAFLEX™ CORD I Study Published in New England Journal of Medicine
09/03/2009 BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
08/12/2009 BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
08/04/2009 BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
07/22/2009 BioSpecifics Technologies Corp. to Present at CapStone Investments’ Third Annual Small-Cap Investor Conference
06/29/2009 BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
05/10/2009 BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
04/27/2009 BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytren's Disease
03/29/2009 BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
01/05/2009 BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
12/17/2008 BioSpecifics Announces Partnership Between Pfizer and Auxilium for XIAFLEX™ in Europe
11/19/2008 BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
09/24/2008 BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Director
09/16/2008 BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease
09/04/2008 BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease
08/19/2008 BioSpecifics Technologies Corp. Announces Private Placement Offering
08/10/2008 BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
06/02/2008 BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
02/04/2008 BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
01/13/2008 BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
10/19/2007 BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
02/20/2007 BioSpecifics Technologies Corp. Mourns Death of Chairman and CEO Edwin H. Wegman
03/08/2006 Change in Assets, Financial Statements & Exhibits
Corporate Presentation February 2010
All SEC Filings
12/17/2009 8-K
12/01/2009 8-K
11/09/2009 8-K
11/06/2009 Q3 2009 Report
11/05/2009 8-K
09/29/2009 8-K
09/17/2009 8-K
09/09/2009 8-K
08/21/2009 8-K
08/13/2009 Q2 2009 Report
08/12/2009 8-K
07/23/2009 8-K
07/15/2009 S-8
06/29/2009 8-K
06/19/2009 8-K
05/12/2009 Q1 2009 Report
05/11/2009 8-K
04/30/2009 DEF 14A
04/29/2009 8-K
03/31/2009 8-K
03/31/2009 2008 Annual Report
03/17/2009 8-K
02/25/2009 CT ORDER
02/17/2009 SC 13G/A
02/17/2009 8-K
02/03/2009 8-K
01/12/2009 8-K
01/07/2009 CERTNAS
01/06/2009 8-A12B
01/06/2009 8-K
11/12/2008 Q3 2008 Report
08/11/2008 Q2 2008 Report
05/15/2008 Q1 2008 Report
2007 Annual Report
Q3 2007 Report
Q2 2007 Report
Q1 2007 Report
2006 Annual Report
2003, 2004, 2005 Annual Reports
Company Code of Ethics
Audit Committee Charter
Compensation Committee Charter
Corporate Governance Guidelines
Nominating and Corporate Governance Charter
Hapoalim Securities
Ram Selvaraju
